The option to use oral semaglutide appeals to some people who make the switch, though real-world experience with oral forms is more mixed than many expect
The NIDDK notes that weight loss exceeding 3 pounds per week is associated with increased gallstone risk, though individual responses vary
The FDA has called out salt forms as not equivalent to the approved active ingredient
It includes an online medical assessment, review by a licensed healthcare provider, insurance coordination when applicable, prescription management and ongoing clinical communication
GLP-1 agonists overall were associated with a 3.67 times higher risk of developing gastroparesis compared to non-users, but within that elevated risk category, tirzepatide appears significantly safer than semaglutide
The demand for pharmaceutical weight-loss drugs has surged alongside the growing obesity crisis, marking a significant trend in recent years